Navigation Links
Examination Chair OC-2300

ProductsExamination Chair OC-2300
Company Topcon America Corporation
Item Examination Chair OC-2300
Features 
Description User programmable memory two position control, illuminated membrane switch control on both chair sides, solid cast aluminum frame, armrest, footrest, and base. One hand articulating headrest, securely locking hand brake with handle on both chair sides, ergonomically contoured cushions with anti-viral upholstery, self-lubricating hinges and bushings, foot pedal control, choice of upholstery colors. Optional features: Surgical upholstery package, dual function foot pedal control.
Info Topcon America Corporation
Customer Service: (800) 223-1130
Web site: http://www.topcon.com/home.html

Related medicine products :

1. Examination Chair OC-2100
2. Examination Chair OC-210
3. Examination Chair OC-2200
4. Examination Chair OC-2400
5. optomap Retinal Examination
6. Polymed® TLC Powder-Free Latex Examination Gloves with Vitamin E
7. Midmark 622 Barrier-Free™ Examination Tables
8. Parasitology Examination
9. Luneau L38 Chair
10. Sun Design Chairs
11. Reliance 6200 Patient Chair
The 90XiIII printer is ideal for applications that require small, high-resolution bar code labels, such as tracking printed circuit boards and small parts, and identifying small products. The printer
Transfuse-ID™, a bedside Transfusion Verification System, is used by hospitals to ensure that a patient receives the specific unit(s) of blood that was typed and crossmatched for them. It has th
The 140XiIII is the fastest barcoding printer in the Zebra Xi Series. With such powerful performance and steel construction, it is the ideal choice for high-volume, mission-critical applications with
wBloodCare™ provides functionality at the bedside to ensure that the correct patient receives the correct blood product.
Medicine Products:
(Date:12/3/2008)...Dec. 3 The gold coin tr...the 26th year gold has been dropped into the red k...ekend. The one-ounce 2005 Liberty $50 coin was wra...y red kettle at a Jewel Food Store in Norridge. ,...n McHenry County in 1982, The Salvation Army has s...
(Date:12/3/2008)...Vt., Dec. 3 In response to press r...ifficult economy, a nutritional expert,and a lead...nts to breastfeed,or use formula responsibly by f... is critical that parents refrain from diluting ba...onomic times," said Barbara S. Levine, R.D., Ph.D....
(Date:12/3/2008)...Dec. 3 Medicsight PLC, an industry...ed Detection (CAD) and medical image analysis soft...tudy that demonstrated CAD significantly increased...lorectal cancers in multi-row detector CT (MDCT) c...hat when both expert and non-expert CTC readers us...
(Date:12/3/2008)...ve effect on teeth and antioxidants provide health...SNewswire/ -- Today, the average size soft drink i...re startling is that some citric acids found in fr...ulfuric acid -- which is also known as battery aci...d citrus juice promote tooth erosion, which wears ...
Breaking Medicine News(10 mins):Health News:Cornell Nutritional Expert, Vermont Baby Formula Company Urge Parents Not to Dilute Formula with Extra Water 2Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 2Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 3Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 4Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 5Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 6Health News:Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis 7Health News:Drink Brewed Tea to Avoid Tooth Erosion 2Health News:Drink Brewed Tea to Avoid Tooth Erosion 3
...tiny human liver has been grown from umbilical cor...cientists. This eliminates //the need for animal e...entists, this mini liver, the size of a 1p coin, i...gments that can be made use of to mend damaged liv...
...e backbone of Kerala's economy has always been the...mous backwaters// attracting visitors from all ove...ical tourism with the state government appearing t...ination of fun and well. Tourists like 50-year-ol...
...potent Asian men are reluctant to seek medical tre...Tuesday//. A recent study of 10,900 men found erec...n China, South Korea, Malaysia and Japan, the Sout... But Andrew Yip Wai-chun, honorary consultant at t...
...research team has identified a key enzyme responsi...in allergic reaction, according to new study findi...ogy. The work by researchers from Virginia Common...pecial Surgery and Weill Cornell Medical College i...
Other Medicine News:Health News:Artificial Liver from Cord Blood Stem cells 2Health News:Kerala to Venture into Medical Tourism 2Health News:Key Signaling Switch Identified in Allergic Disease 2
(Date:12/1/2008)...ire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasd...one of the world,s leading medical journals, resul...ator, experimental compound tasimelteon (VEC-162)....ed "Melatonin agonist tasimelteon (VEC-162) for tr...mised controlled multicentre trials." Results are ...
(Date:12/1/2008)... Treated With ENB-0040 at Children,s Hospital, Hea...L, Dec. 1 Enobia Pharma, an emergi...novel therapeutics for serious bone disorders, tod...clinical program for hypophosphatasia was dosed. E...(ERT) with ENB-0040 for the treatment of this rare...
(Date:12/1/2008)...r 1 Following a,Request...ocure an MVA-based,third generation smallpox vac..., on behalf of the Canadian Department of National...ic for the delivery of IMVAMUNE(R). , The C...art of the,country,s bio-preparedness programme. ...
(Date:11/30/2008)...Newswire-USNewswire/ -- Older adults who exercise ... greater number of small blood vessels in the brai...nual meeting of the Radiological Society of North ...t the University of North Carolina ( UNC) - Chap...lder adults who exercise to brain scans of those w...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3California Small Business Association Condemns California Nurses Associations Decision to Call Prolonged Strike at Hospitals Throughout Northern Calif 14051 1California Small Business Association Condemns California Nurses Associations Decision to Call Prolonged Strike at Hospitals Throughout Northern Calif 14051 2California Small Business Association Condemns California Nurses Associations Decision to Call Prolonged Strike at Hospitals Throughout Northern Calif 14051 3Structure for Success 3A Leadership Development Programs at Pharmaceutical Companies 14048 1Structure for Success 3A Leadership Development Programs at Pharmaceutical Companies 14048 2Scientists to discover why flamingos are in the pink of health in the poo 21 2465 1Scientists to discover why flamingos are in the pink of health in the poo 21 2465 2Hospital Leaders Urge Legislators Not to Further Destabilize Floridas Healthcare Landscape 14044 1Hospital Leaders Urge Legislators Not to Further Destabilize Floridas Healthcare Landscape 14044 2Hospital Leaders Urge Legislators Not to Further Destabilize Floridas Healthcare Landscape 14044 3
...Portola,Pharmaceuticals, Inc. announced positive P...ral Factor Xa inhibitor, today at the XXI,Congress...emostasis,(ISTH) in Geneva, Switzerland. The EXPER... and well tolerated for the,prevention of venous t...total knee replacement (TKR) surgery. Portola expe...
... Trial -, MISSISSAUGA, ON, July 11, 2007 /PRNewswi...company that identifies, develops,and commercializ...,today announced results of secondary endpoint dat...led, multi-center Phase IIb,trial (DLXLEF-AP4) wit...livery composition of free and liposome-encapsulat...
Other Medicine Technology:Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 2YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 3YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 4YM BioSciences Announces Secondary Efficacy and Safety Findings in,Randomized Phase IIB Aerolef Trial 5